The domestic pharmaceutical market, currently valued at $ 60 billion, is projected to more than double to $130 billion by 2030. In FY25, the sector recorded an annual turnover of ₹4.72 lakh crore, with exports growing at a steady CAGR of 7% over the past decade. India’s dominance in generic medicines, accounting for nearly 20% of global supply, underlines its critical role in global healthcare delivery.
Powering Public Health And Economic Growth
India’s pharmaceutical sector plays a pivotal role in improving public health outcomes while driving industrial and employment growth. By ensuring access to essential medicines and vaccines, the industry supports both domestic healthcare systems and global health priorities, while strengthening supply chain resilience and socio-economic progress.
Global Leadership Backed By Scale and Quality
Country’s reputation as the “Pharmacy of the World” is anchored in its ability to deliver high-quality medicines at competitive costs. The industry ranks third globally by volume and 11th by value, supported by a vast network of over 3,000 companies and 10,500 manufacturing units.
This scale is complemented by strong regulatory credibility, with India hosting the highest number of USFDA-approved manufacturing plants outside the United States. Additionally, the country’s 500 API manufacturers contribute nearly 8% to the global API market, cementing its position in the global pharmaceutical value chain.
Export Strength And Global Reach
Exports have expanded significantly, reaching $30.5 billion in FY25, with shipments to 191 countries. Notably, around 50% of exports are directed towards highly regulated markets such as the US and Europe, reflecting strong international confidence in Indian medicines.
India is also a global vaccine leader, supplying approximately 60% of UNICEF’s vaccine requirements and meeting a substantial share of global demand for DPT, BCG, and measles vaccines. This leadership highlights the sector’s critical role in global immunisation efforts.
Strategic diversification into emerging markets, including Nigeria, Mexico, Brazil, Saudi Arabia, and Spain, has enhanced export resilience and reduced dependency on specific geographies.
Rising Investments Signal Confidence
The pharmaceutical sector continues to attract strong foreign investment, ranking among the top 10 industries for FDI inflows in India. With investments reaching ₹13,193 crore in FY26 (up to September), the sector reflects growing global confidence driven by policy stability, expanding capacity, and its role as a global manufacturing hub.